Estrogen receptors: molecular interactions, virtual screening and future prospects

Area of Science:

• Medicinal Chemistry
• Computational Biology
• Pharmacology

Background:

• The Estrogen Receptor (ER) is crucial in breast cancer proliferation, osteoporosis, and coronary heart disease.
• Advances in ER crystal structures enhance understanding of its modulation mechanisms.
• Selective Estrogen Receptor Modulators (SERMs) are key therapeutic agents.

Purpose of the Study:

• To explore computational techniques for rational drug design targeting the ER.
• To investigate the chemical space of antiestrogens using Principal Component Analysis (PCA).
• To validate docking algorithms for Virtual Screening (VS) of ER modulators.

Main Methods:

• Principal Component Analysis (PCA) of 145 molecular descriptors.
• Review and validation of docking algorithms using ER structural data.
• Cavity analysis to identify alternative ER binding pockets.

Main Results:

• PCA differentiated antiestrogen chemical space from general 'drug-like' space.
• Enrichment (E) and False Positive (FP) rates were used to assess docking algorithm performance.
• A model for concurrent genomic and non-genomic ER signaling via a second binding pocket was proposed.

Conclusions:

• Computational methods combined with structural data enable rational design and VS of ER modulators.
• Docking algorithms show varying success rates in ER-targeted VS.
• A novel binding pocket model explains dual ER signaling pathways.